美股A股
StockGist
Back
6-K2026-05-06· glm-5

IPHA · Innate Pharma S.A.

0001628280-26-030874

SEC filing

Summary

Innate Pharma S.A. announced it will hold a conference call and webcast on May 13, 2026, to provide a business progress update for the first quarter of 2026.

Key takeaways